1. A pharmaceutical composition containing an active principle selected from compounds of the jasmonate family and their derivatives, and any molecules, and / or possibly compositions and / or compounds in the volume and / or inside and / or on the surface of the nanocarrier or microcarrier used in as host molecules and capable of protecting molecules of jasmonate family compounds and any derivatives thereof from chemical and / or any other reactions occurring in the medium, structural changes, such as the addition and / or conjugation of molecules representing a prolek, are possible substances, and / or the creation of compounds with multiple effects, in order to enhance the action of the active principle, and / or a derivative of the molecules of the jasmonate family and any derivatives thereof, in the composition, in volume, and / or inside, and / or on the surface of the nanocarrier or microcarrier of any type may be useful in enhancing the type of action that you plan to achieve； in this case, structural changes should be understood as possible changes in the structure of the cyclopentanone ring, leading either to its transformation into a cyclopentenone ring, or to any other compounds by possible addition and / or conjugation reactions, and / or any other natural and / or synthetic reactions, in any parts of molecules of compounds of the jasmonate family and their derivatives inside any kind of nanocarriers and / or any kind of microcarriers in order to improve the properties of these molecules, more specifically the molecules of compounds of this jasmonate-keeping and any derivatives thereof and any possible compounds in formulations used in concentrations in the range of zero to one mole equivalents based1. Фармацевтический состав, содержащий активное начало, выбранное из соединений семейства жасмонатов и их производных, и любые молекулы, и/или возможно составы и/или соединения в объеме, и/или внутри, и/или на поверхности наноносителя или микроносителя, прим
